Answer
Jun 12, 2025 - 12:13 PM
Verzenio is used to treat HR+ (hormone receptor-positive), HER2- (human epidermal growth factor receptor 2-negative), node-positive, early breast cancer with possible recurrence and certain types of HR+ and HER2- breast cancer that has spread to other parts of the body. This treatment targets specific types of breast cancer, providing a tailored approach that can be more effective for those conditions.